ArticlePDF Available

Survey of the Use of Peripherally Inserted Central Venous Catheters in Children

Authors:

Abstract

Use of peripherally inserted central venous catheters (PICCs) to provide prolonged intravenous (IV) access in children is increasing. Our goal was to describe the children treated with PICCs in our institution, and to study catheter features such as catheter life, completion of therapy, and complications. Furthermore, we also evaluated PICC use in children completing therapy after discharge from our institution. A prospective study of all PICCs inserted at the Children's Hospital and Medical Center (CHMC), a university-affiliated teaching institution, during a period of 18 months (January 1994 to July 1995). A total of 441 PICCs were inserted in 390 patients. Patient age ranged from 0 to 22 years with a mean of 5.4 +/- 6.0 years. No insertion complications occurred. Treatment of infectious disease (46%) was the most frequent reason for PICC insertion. All pediatric medical and surgical services used PICCs. Average catheter life was 13 +/- 12 days. Sixty-one percent of PICCs were used entirely at CHMC, while 39% were also used at home or at an outside hospital. Completion of therapy was achieved in 69% of PICCs. Among children who completed therapy outside our hospital, there was no difference in the rates of occlusion, accidental dislodgment, or infection. One hundred twenty-nine (29%) PICCs were removed for complications. Occlusion (7%), accidental displacement (8%), and suspicion of sepsis (8%) were the most common complications. Only 2% of PICCs had documented catheter-associated sepsis. PICCs provide reliable and safe access for prolonged IV therapy in neonates and children. The low incidence of complications with PICCs make them an attractive device for prolonged IV access. Similar complication rates with use in and out of hospital suggest that home IV therapy can be safely delivered with PICCs, avoiding expensive hospitalization.
DOI: 10.1542/peds.99.2.e4
1997;99;e4Pediatrics
Ravi R. Thiagarajan, Chandra Ramamoorthy, Theresa Gettmann and Susan L. Bratton
Survey of the Use of Peripherally Inserted Central Venous Catheters in Children
http://pediatrics.aappublications.org/content/99/2/e4.full.html
located on the World Wide Web at:
The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 1997 by the American Academy
published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
publication, it has been published continuously since 1948. PEDIATRICS is owned,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
Survey of the Use of Peripherally Inserted Central Venous Catheters in
Children
Ravi R. Thiagarajan, MBBS, MRCP*; Chandra Ramamoorthy, MBBS, FRCA*; Theresa Gettmann, RN, BSN‡;
and Susan L. Bratton, MD, MPH*
ABSTRACT. Objective. Use of peripherally inserted
central venous catheters (PICCs) to provide prolonged
intravenous (IV) access in children is increasing. Our
goal was to describe the children treated with PICCs
in our institution, and to study catheter features such
as catheter life, completion of therapy, and complica-
tions. Furthermore, we also evaluated PICC use in
children completing therapy after discharge from our
institution.
Methods. A prospective study of all PICCs inserted at
the Children’s Hospital and Medical Center (CHMC), a
university-affiliated teaching institution, during a period
of 18 months (January 1994 to July 1995).
Results. A total of 441 PICCs were inserted in 390
patients. Patient age ranged from 0 to 22 years with a
mean of 5.4 66.0 years. No insertion complications oc-
curred. Treatment of infectious disease (46%) was the
most frequent reason for PICC insertion. All pediatric
medical and surgical services used PICCs. Average cath-
eter life was 13 612 days. Sixty-one percent of PICCs
were used entirely at CHMC, while 39% were also used
at home or at an outside hospital. Completion of therapy
was achieved in 69% of PICCs. Among children who
completed therapy outside our hospital, there was no
difference in the rates of occlusion, accidental dislodg-
ment, or infection.
One hundred twenty-nine (29%) PICCs were removed
for complications. Occlusion (7%), accidental displace-
ment (8%), and suspicion of sepsis (8%) were the most
common complications. Only 2% of PICCs had docu-
mented catheter-associated sepsis.
Conclusions. PICCs provide reliable and safe access
for prolonged IV therapy in neonates and children. The
low incidence of complications with PICCs make them
an attractive device for prolonged IV access. Similar
complication rates with use in and out of hospital sug-
gest that home IV therapy can be safely delivered with
PICCs, avoiding expensive hospitalization. Pediatrics
1997;99(2). URL: http://www.pediatrics.org/cgi/content/
full/99/2/e4; peripherally inserted central venous catheter,
vascular access, catheter related sepsis, completion of
therapy, occlusion, accidental dislodgment, home therapy,
phlebitis.
ABBREVIATIONS. PICC, peripherally inserted central venous
catheter; IV, intravenous; TPN, total parenteral nutrition; CHMC,
Children’s Hospital and Medical Center; SVC, superior vena cava;
IVC, inferior vena cava.
Peripherally inserted central venous catheters
(PICCs) are frequently used to provide prolonged
intravenous (IV) access in both acute and home care
settings. Shaw described PICC use in 1973 as a
method of providing reliable vascular access for total
parenteral nutrition (TPN) in neonates.1,2 PICCs were
subsequently used to provide IV access for adminis-
tration of prolonged antibiotic courses in children
with cystic fibrosis during pulmonary exacerba-
tions.3PICCs lasted twice as long as conventional
peripheral IV cannulae, reducing the number of ve-
nipunctures by half and enabling home therapy.3
PICC utilization has continued to increase because
these catheters are easy to insert and have a low
incidence of complications compared with other sur-
gically placed central lines.2,4–10
PICCs are made of biocompatible material, usually
polyurethane or silicone. Insertion is simple and is
usually done by nursing personnel who have com-
pleted a recommended certification process.6The
success rate for insertion of PICCs ranges from 78%
to 92%.4,5,11,12 Veins of the antecubital fossa are com-
monly used; however, the saphenous, axillary, or
even scalp veins can be used.3,6,9 Complications asso-
ciated with PICC insertion are infrequent, but in-
clude bleeding, tendon or nerve damage, cardiac
arrhythmias, chest pain, catheter malposition, and
catheter embolism.5–7
Few studies have examined the use of these cath-
eters in a large pediatric population. We examined
PICC utilization in a university-affiliated children’s
hospital. Our goals were to describe the patient pop-
ulation treated with PICCs as well as catheter fea-
tures such as average catheter life, completion of
therapy, reasons for removal, and complications. Fi-
nally, we compared PICC-related data of children
receiving therapy at home, or at an outside hospital,
with those hospitalized for the entire time of PICC
use.
METHODS
Information was prospectively collected on all PICCs inserted
at Seattle Children’s Hospital and Medical Center (CHMC) during
an 18-month period from January 1994 to July 1995. PICCs were
inserted primarily by the IV nursing team. Referrals for catheter
From the *Department of Anesthesiology, University of Washington School
of Medicine, Department of Anesthesia and Critical Care, Children’s Hos-
pital and Medical Center, Seattle, Washington; and the ‡Department of
Nursing, Children’s Hospital and Medical Center, Seattle, Washington.
Received for publication Apr 19, 1996; accepted Jul 16, 1996.
Address correspondence to: Susan L. Bratton, MD, MPH, Department of
Anesthesia and Critical Care, Children’s Hospital and Medical Center, 4800
Sandpoint Way NE, Seattle, WA 98105.
PEDIATRICS (ISSN 0031 4005). Copyright © 1997 by the American Acad-
emy of Pediatrics.
http://www.pediatrics.org/cgi/content/full/99/2/e4 PEDIATRICS Vol. 99 No. 2 February 1997 1of4
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
placement occurred at the discretion of the patient’s primary
physician and were made directly to the IV team.
All insertions were done as inpatient procedures. Per-Q-Cath
(Gesco Inc, San Antonio, TX) or L-Cath (Luther Medical Products
Inc, Tustin, CA) catheters of sizes ranging from 2- to 5-French
(catheter size 23-gauge to 16-gauge) were used. The size and
choice of catheter was determined by the IV team member insert-
ing the catheter. Anesthesia was provided with 1% lidocaine local
infiltration or EMLA cream (Astra Pharmaceuticals, Westborough,
MA), supplemented when needed with oral chloral hydrate or IV
midazolam.
Patient preparation and insertion techniques were standard-
ized by hospital protocol. After a suitable vein for insertion was
identified, the area of skin at the proposed insertion site was
cleaned with povidone-iodine solution, and covered with sterile
drapes. The IV team member inserting the catheter wore a cap,
mask, sterile gown, and sterile gloves. After infiltrating the site
with 1% lidocaine, the vein was punctured using the introducer
needle. The catheter was then inserted through the needle, to a
premeasured length. The needle was then removed and the exit
site was dressed with dry sterile gauze. The dressing was changed
every week, or earlier if soiled. The location of the catheter tip was
determined radiographically. When the tip was not easily visible
by the plain radiograph, contrast material injected through the
catheter was used to delineate the tip. The tip was considered to be
in a central vein if it was placed in the superior vena cava (SVC),
the inferior vena cava (IVC), or subclavian vein. Afterwards, cath-
eter care was administered by the nurses caring for the patient. At
insertion, patient demographic information was recorded on a log
sheet by the IV team member inserting the catheter. The IV team
monitored these catheters closely and recorded complications for
the duration of catheter use on the log sheet.
PICCs were used for IV fluid therapy, administration of med-
ication, and blood products. TPN solutions with dextrose concen-
trations of more than 12.5% were administered through centrally
placed catheters. Catheters were accessed continuously or inter-
mittently. For PICCs accessed continuously, the use of heparin to
maintain line patency was at the discretion of the primary physi-
cian. When PICCs were accessed intermittently, they were flushed
with heparin-containing saline solution after each use. Insertion
and removal complications were noted. For patients who were
discharged home or to another institution with a catheter in situ,
care was given by local nursing personnel, maintaining telephone
contact with the IV team at CHMC.
PICCs were removed for various reasons including: completion
of therapy, occlusion, accidental dislodgement, and suspicion of
catheter-associated infection. The following definitions were used
to define infectious complications: 1) phlebitis was defined as
inflammation tracking along the course of the vein from the in-
sertion site, with or without a palpable venous cord; 2) exit-site
infection was present when inflammation and purulent discharge
were noted at the insertion site; and 3) catheter-associated sepsis
was diagnosed in patients with fever without another identifiable
source, who had a positive blood or catheter-tip culture (Maki roll
technique).
To compare catheter use and function in different age groups,
patients were divided into four groups: 0 to 30 days old; 31 days
to 1 year old; 1 to 5 years old; and older than 5 years. Continuous
data were compared with analysis of variance and the ttest.
Adjustments for multiple comparisons were done with the
Tukey-B test. Categorical data were compared using the
x
2and
Fisher’s exact tests. Significance was defined as P,.05.
RESULTS
A total of 444 PICCs were inserted in 390 patients
during the 18-month period. Data was complete for
441 of 444 PICC insertions. Demographic informa-
tion of the study subjects is presented in Table 1. The
median age of patients in the group was 3.4 years
(range 0 days to 22 years). No complication from
insertion was noted.
Catheter size ranged from 2- to 5-French (Table 2).
Three-French catheters were most frequently used in
all ages (48%). Two-French was the most commonly
used catheter size in the 0 to 30 day group (93%) and
in infants 31 days to 1 year old (85%), while 3-French
was most commonly used in children 1 to 5 years old
(60%) and older than 5 years (82%). The veins most
commonly accessed were antecubital (89%). The tip
was located in a central location in 53% of insertions
and a peripheral location in 47% of insertions.
Antecedent medical diagnosis and services refer-
ring patients for PICC placement are outlined in
Tables 3 and 4. Treatment of infectious disease was
the most common cause for PICC insertion (46%).
Referral for PICC insertion was most commonly
made by the general pediatric service (20%); how-
ever, PICCs were used by most pediatric medical
and surgical subspecialty services.
Sixty-one percent of PICCs were used entirely in
CHMC, while 39% were also used at home or in a
referring community hospital. The average catheter
life was 13 612 days. Neither patient age nor cath-
eter lumen size were significantly related to catheter
life. Catheter lives for each lumen size were 2-French
(12.9 days), 2.7-French (11 days), 3-French (12.4
days), 4-French (16.6 days), and 5-French (13.4 days).
Completion of therapy was achieved with 69% of
catheters. Significantly fewer PICCs used entirely at
CHMC (69%) completed therapy compared with
those used outside the institution (77%), (P5.01).
A total of 129 PICCs (29%) were removed for com-
plications (Table 5) with accidental dislodgement
TABLE 1. Patient Demographic Information
n (%)
Total number of patients 390
Total PICC lines (N) 441
Males 252 (57)
Females 189 (43)
Age
0–30 days 118 PICCs (27)
30 days–1 year 66 PICCs (15)
1–5 years 62 PICCs (14)
.5 years 195 PICCs (44)
CHMC use only 271 (62)
Outside use 170 (38)
Abbreviations: PICC, peripherally inserted central venous cathe-
ters; CHMC, Children’s Hospital and Medical Center.
TABLE 2. Catheter Characteristics
n%
Catheter size
2-French 192 43
2.7-French 1 0.2
3-French 212 49
4-French 31 7
5-French 5 1
Veins accessed
Antecubital 393 89
Saphenous 37 9
Others 11 3
Tip placement
Deep arm 178 40
Superior vena cava 106 24
Subclavian 99 22
Deep leg 18 4
Right atrium 12 3
Inferior vena cava 10 2
Iliacs 8 2
Not recorded 10 2
2of4 PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
(8%), suspected infection (8%), and occlusion (7%)
being the most common reasons. No increase in oc-
clusion rate between home and hospital use was
found. Occlusion was significantly more common
with smaller lumen sizes. Eleven percent of 2-French
catheters became occluded compared with 4% of 3-
French and 7% of 4-French catheters. Accidental dis-
lodgement was more common with older infants 31
days to 1 year old and children 1 to 5 years old (17%
and 11.3%, respectively) than in those 0 to 30 days
old or children older than 5 years (5.9% and 4.6%,
respectively). The influence of the methods used to
secure PICCs on the incidence of dislodgement could
not be determined. Rate of dislodgement did not
differ between out of CHMC use and CHMC use.
A total of 37 PICCs (8%) were removed for sus-
pected catheter infection. Fourteen PICCs (3%) were
removed because of fever without another identifi-
able source. Nine (2%) were associated with a posi-
tive blood or catheter tip culture (catheter-associated
sepsis). Of these, 8 PICCs were used only in CHMC,
while 1 PICC was used outside CHMC. Coagulase
negative staphylococcus species, enterococcus, Esch-
erichia coli, and candidia species were the organisms
cultured from blood or catheter tip in patients with
documented catheter-associated sepsis. Eight PICCs
(2%) were removed due to purulent drainage and
inflammation at exit site. Of these, 6 PICCs were
used in CHMC and 2 outside. Phlebitis resulted in
the removal of 16 PICCs (3.6%)—10 during use at
CHMC compared with 6 during outside use. Patients
whose PICCs were removed for exit site infection or
phlebitis did not have fever or other signs of sys-
temic sepsis.
TPN solutions were administered in 34% of cath-
eters. TPN administration did not decrease catheter
life (14.1 days) compared with catheters not used for
TPN administration (12.2 days). Seven cases of cath-
eter-associated sepsis occurred in children receiving
TPN; however, this association was not statistically
significant. No complications were noted during
catheter removal and no deaths were directly attrib-
uted to PICC use.
One infant developed bilateral pleural effusions 1
week after PICC placement for TPN administration
with the catheter tip located in the SVC. Fluid
drained from the pleural space had glucose and tri-
glyceride levels similar to the TPN administered
through the PICC, which was removed. The pleural
effusions did not recur and the infant recovered.
DISCUSSION
Our study demonstrated that PICCs are a safe and
reliable IV access device in neonates and children.
They are also safe in the home setting if parents and
home nursing personnel are properly instructed in
catheter care and recognition of catheter complica-
tions.
In our study, PICCs were used by a wide range of
pediatric subspecialties, therapy was completed in
two thirds of PICCs inserted and the incidence of
phlebitis and catheter-associated sepsis was low. Pa-
tients using PICC for therapy outside our institution
had similar catheter life and completion of therapy
rates. Complications associated with PICC use out-
side were fewer compared with their exclusive hos-
pital use. This is not surprising because hospitalized
children are typically sicker and have increased risk
of nosocomial infections and exposure to multiple
medications, increasing the risk of thrombophlebitis.
Prior reports of therapy completion have ranged
from 50% to 96% in patients with a single PICC.6,8
Our study demonstrated therapy completion in 69%
of PICCs. The increased occlusion rate in smaller-
lumen catheters, however, did not significantly
lower the rate of completion of therapy in infants
compared with older children. PICCs in our study
were used in many patients who required prolonged
IV access. An average catheter life of almost 2 weeks
provided prolonged uninterrupted IV access. The
longest catheter life in our study was 132 days. No
limits as to the duration of leaving the catheter in situ
have been established.6,13
No complications were related to catheter inser-
tion. Risks associated with placement of PICCs are
TABLE 3. Antecedent Diagnosis
Diagnosis n %
Infectious diseases 205 46
Prematurity 77 18
Cystic fibrosis 51 12
Malignancy 27 6
Surgical abdomen 21 5
Inflammatory bowel disease 5 1
Dehydration 5 1
Miscellaneous 49 11
Not recorded 1 0.2
TABLE 4. Referring Services
Service n %
General pediatrics 90 20
Neonatal ICU 76 17
Pulmonary 66 15
General surgery 65 15
Hematology-oncology 32 7
Cardiothoracic surgery 20 5
Renal 16 4
Pediatric intensive care unit 11 3
Gastroenterology 9 2
Cardiology 5 1
Other medical services 5 1
Other surgery 44 10
Not recorded 2 0.5
TABLE 5. Reason for Removal of Peripherally Inserted Cen-
tral Venous Catheters: CHMC vs Outside Use
Reason Total n
(%) CHMC Use
n (%) Outside Use
n (%)
Total number 441 271 170
Therapy complete 305 (69) 175 (65) 130 (77)
Suspected infection 37 (8) 28 (10) 9 (5)
Occlusion 32 (7) 20 (7) 12 (7)
Accidental dislodgement 34 (8) 21 (8) 13 (8)
Leakage 7 (2) 6 (2) 1 (1)
Breakage 8 (2) 6 (2) 2 (1)
Infiltration 9 (2) 8 (3) 1 (1)
Catheter rupture 2 (1) 1 (0.4) 1 (1)
Placement incorrect 2 (1) 2 (1) 0 (0)
Removed after death 5 (1) 4 (2) 1 (1)
Abbreviation: CHMC, Children’s Hospital and Medical Center.
http://www.pediatrics.org/cgi/content/full/99/2/e43of4
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
very low; thus, catheters can be replaced at another
site without putting a patient at significant risk.9,10
Furthermore, accessibility of peripheral veins for
compression make control of bleeding easy during
insertion. Therefore, PICCs can be used safely in
patients with a bleeding diathesis to provide central
access for therapy.9
About 30% of PICCs in our study were removed
for complications. Occlusion was more common in
2-French catheters (the smallest lumen) than with
others. This finding is similar to the study in adults,
where occlusion was more common in smaller cath-
eters (18-gauge vs 20-gauge).9Occlusion can some-
times be relieved by flushing with urokinase.6,8,9
However, excessive force to flush catheters may re-
sult in catheter rupture or cause thromboembolism.9
Occluded catheters that cannot be relieved with gen-
tle flushing should be removed and replaced.9Al-
though catheters can break or rupture at the external
portion, they can be repaired with the repair kit
supplied without having to replace the catheter.6
Catheter-associated sepsis requires removal of the
catheter and appropriate antibiotic therapy. The in-
cidence of catheter-associated sepsis with PICCs
ranged from 0 to 2.2% in previous studies.6,8,9,12 In our
study, the incidence of catheter-associated sepsis
(2%) was similar to previous reports and lower than
catheter-associated infection associated with other
central venous devices (3% to 20%) or peripheral
venous catheters (4.6% to 9%).9,10,14,15 The incidence of
infections tended to be higher with PICCs used in the
hospital and with TPN administration; however, this
was not statistically significant.
The occurrence of pleural effusion in one patient
was a serious complication of PICC use. Although,
no complications were noted with PICC removal,
difficulty with removal attritubable to fibrin deposi-
tion around the catheter may occur as a rare compli-
cation.6
In conclusion, PICCs are a reliable method of pro-
viding prolonged IV therapy in children of all ages.
Decreased number of catheter placements, compared
with peripheral IV catheters per therapy, can be ex-
pected to decrease patient pain and apprehen-
sion.3,4,6– 8 PICCs have fewer insertion and infectious
complications compared with other central venous
devices. Furthermore, these catheters allow safe com-
pletion of IV therapy outside the hospital setting,
saving continued expensive hospitalization. Mea-
sures to prevent accidental dislodgement in infants
and children younger than 5 years old must be rein-
forced. Care givers of patients discharged home with
an indwelling catheter must be taught good aseptic
techniques and be advised to seek medical advice if
the patient develops fever or catheter-related pain.
PICCs can provide safe and prolonged IV access
for neonates and children in the hospital or home
setting.
REFERENCES
1. Shaw JCL. Parenteral nutrition in the management of sick low birth-
weight infants. In: Gluck L, ed. Pediatr Clin North Am. Philadelphia, PA:
WB Saunders Company; 1973;20:333–358
2. Puntis JWL. Percutaneous insertion of central venous feeding catheters.
Arch Dis Child. 1986;61:1138–1140
3. Williams J, Smith HL, Woods CG, Weller PH. Silastic catheters for
antibiotics in cystic fibrosis. Arch Dis Child. 1988;63:658–659
4. Sheppard R, Ong TH. Evaluation of percutaneously inserted peripheral
silicone catheters for parental nutrition in infants and children. Aust
Paediatr J. 1980;16:181–184
5. Dolcourt JL, Bose CL. Percutaneous insertion of silastic central venous
catheters in newborn. Pediatrics. 1980;70:484–486
6. Frey AM. Pediatric peripherally inserted central catheter program re-
port. J Intraven Nurs. 1995;18:280–291
7. Brown JM. Peripherally inserted central catheters use in home care.
J Intraven Nurs. 1989;12:144–147
8. Dietrich KA, Lobas JG. Use of single silastic IV catheter for cystic
fibrosis pulmonary exacerbations. Pediatr Pulmonol. 1988;4:181–184
9. Lam S, Scannell R, Roessler D, Smith M. Peripherally inserted central
catheters in an acute-care hospital. Arch Intern Med. 1994;154:1833–1837
10. Giufrida DJ, Bryan-Brown CW, Lumb PD, Kwun KB, Rhoades HM.
Central vs peripheral venous catheters in critically ill patients. Chest.
1986;90:806–809
11. Kyle SK, Myers JS. Peripherally inserted central catheters: Development
of a hospital based program. J Intraven Nurs. 1990;13:287–290
12. Markel S, Reynen K. Impact on patient care: 2652 PIC catheter days in
the alternative setting. J Intraven Nurs. 1990;13:347–351
13. Rutherford C. A study of single lumen peripherally inserted central line
catheter dwelling time and complications. J Intraven Nurs. 1988;11:
169–173
14. Orr ME. Issues in the management of percutaneous central venous
catheters. In: Fulton JS, ed. Nurs Clin North Am. Philadelphia, PA: WB
Saunders Company; 1993;28:911–919
15. Loughran SC, Edwards S, McClure S. Peripherally inserted central
catheters. Guidewire versus nonguidewire use: a comparative study.
J Intraven Nurs. 1992;15:152–159
4of4 PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
DOI: 10.1542/peds.99.2.e4
1997;99;e4Pediatrics
Ravi R. Thiagarajan, Chandra Ramamoorthy, Theresa Gettmann and Susan L. Bratton
Survey of the Use of Peripherally Inserted Central Venous Catheters in Children
Services
Updated Information & http://pediatrics.aappublications.org/content/99/2/e4.full.html
including high resolution figures, can be found at:
References
#ref-list-1
http://pediatrics.aappublications.org/content/99/2/e4.full.html
at:
This article cites 13 articles, 2 of which can be accessed free
Subspecialty Collections
disease
http://pediatrics.aappublications.org/cgi/collection/infectious_
Infectious Disease & Immunity
following collection(s):
This article, along with others on similar topics, appears in the
Permissions & Licensing
ml
http://pediatrics.aappublications.org/site/misc/Permissions.xht
tables) or in its entirety can be found online at:
Information about reproducing this article in parts (figures,
Reprints http://pediatrics.aappublications.org/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Village, Illinois, 60007. Copyright © 1997 by the American Academy of Pediatrics. All rights
trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove
andpublication, it has been published continuously since 1948. PEDIATRICS is owned, published,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on June 3, 2013pediatrics.aappublications.orgDownloaded from
... 1,2 Pediatric PICC was initially introduced in the 1970s for parenteral nutrition in neonates. [1][2][3] is considered an alternative and/or a supplement to conventional venous lines. 4 Over time, PICC has also found uses in providing long-term intravenous access for medications such as antibiotic regimens in children. ...
... 5 Generally, the indwelling duration of a PICC ranges from 0 days to 6 weeks. 1 An uncomplicated PICC represents the best practice for children to receive medications, intravenous fluids, or have blood samples taken (for PICCs larger than 2 French). PICC has gained popularity in pediatrics because of its ability to establish safe, long-term intravascular access, provide comfort, reduce the need for repeated venipunctures, and facilitate the transition to home intravenous therapy. ...
Article
Full-text available
Objective: Peripherally Inserted Central Catheters (PICC) are widely used for intermediate to long term venous access. Venipunctures and catheterizations in pediatric patients can be challenging and traumatizing to children’s veins due to frequent and painful needle sticks. This study aims to demonstrate the outcomes of PICC insertion and management in pediatric patients by the Anesthesia Line Service Team (ALiST) at Siriraj Hospital. Materials and Methods: This is a retrospective, descriptive study collecting data from January 2018 to December 2021. The inclusion criteria were pediatric patients aged 15 years and under, body weight equal to or exceeding 5 kg with no history of previous complicated central venous accesses. The primary outcome is the success rate of insertion. Results: 124 PICCs were inserted in pediatric patients. The median age of patients was 5.0 years, with a median height of 107.8 cm, and a median weight of 10.0 kg. The successful insertion rate was 96.92%, and all insertions were inserted using ultrasound-guided technique, with or without fluoroscopy. No acute complications were noted during insertion. Most patients received either intravenous sedation (39.5%) or general anesthesia (26.6%) during the procedure. The mean duration of catheter indwelling was 66.48 days. Reasons for removal of PICC included completion of therapy and patient demise (70.97%), catheter malformation (8.06%), accidental removal (4.03%), infection (8.06%), and patient non-adherence (1.61%). Conclusion: Our research demonstrates a notably high rate of successful PICC placement among pediatric patients, with data indicating a minimal occurrence of complications and an extended duration of catheter usage.
... On the other hand, the insertion of the central line is an extremely delicate technique with a high failure rate. [14][15][16] For infants who require venous access for more than a few days, central lines have become a more common modality of intervention; the optimal vein for catheter insertion should be chosen when the indication for line installation has been confirmed. Basilic or cephalic veins in the upper extremities, temporal or posterior auricular veins in the head, and saphenous veins in the lower extremities are all frequent superficial veins used for catheterization. ...
Article
Full-text available
Objectives to evaluate the accessibility, success rate, and attributable complications and to describe the maneuver for central line insertion via proximal basilic or axillary veins in neonates. Methods This retrospective study included all infants admitted to the neonatal intensive care unit and had an axillary central line inserted or attempted. Success rate, complications, and outcomes were reviewed. Results Axillary central line was attempted in 85 infants and was successful in 78 infants with a success rate of 91.7%. The median postnatal age of patients was 8 days (2 days–92 days), and the median weight of patients at the procedure was 2600 g (590 g–3900 g). The median corrected gestational age of patients at the procedure was 36 weeks (23 weeks–46 weeks). No serious complication was observed in any of the 85 infants. Conclusion This study demonstrated a high success rate for insertion of proximal basilic and axillary veins central lines in neonates with difficult vascular access. This procedure was feasible in very low birth and extremely low birth preterm infants, especially in those who failed previous central line attempts.
... In general, neonatal PICC was first described in 1973 by Shaw as a technique for inserting a silicone catheter into the central veins of neonates (4). Since then, there has been significant improvement in the practice of insertion (5). Although PICCs are relatively easy and quick to obtain, they are not risk-free and have been associated with various complications such as occlusion, infection, thrombosis, breakage, and migration. ...
Article
Full-text available
Background: Peripherally inserted central catheters (PICC) are frequently used in neonatal intensive care units (NICU) to assist premature and critically ill neonates. Massive pleural effusions, pericardial effusions, and cardiac tamponade secondary to PICC are extremely uncommon but have potentially fatal consequences. Objective: This study investigates the incidence of tamponade, large pleural, and pericardial effusions secondary to peripherally inserted central catheters in a neonatal intensive care unit at a tertiary care center over a 10-year period. It explores possible etiologies behind such complications and suggests preventative measures. Study design: Retrospective analysis of neonates who were admitted to the NICU at the AUBMC between January 2010 and January 2020, and who required insertion of PICC. Neonates who developed tamponade, large pleural, or pericardial effusions secondary to PICC insertion were investigated. Results: Four neonates developed significant life-threatening effusions. Urgent pericardiocentesis and chest tube placement were required in two and one patients, respectively. No fatalities were encountered. Conclusion: The abrupt onset of hemodynamic instability without an obvious cause in any neonate with PICC in situ should raise suspicion of pleural or pericardial effusions. Timely diagnosis through bedside ultrasound, and prompt aggressive intervention are critical.
... In newborns, PICC lines are a safe and reliable vascular access. On the other hand, the insertion of the PICC line is an extremely delicate technique with a high failure rate.[11][12][13] For infants who require central venous access for more than a few days, PICC lines have become a more popular modality of intervention; the optimal vein for catheter insertion should be chosen when the indication for PICC installation has been con rmed. ...
Preprint
Full-text available
Purpose of review: to evaluate the accessibility, success rate, and attributable complications and to describe the maneuver for PICC line insertion via proximal basilic or axillary veins in neonates. Recent findings: This study demonstrated a total of 78 PICCs inserted successfully 91.7% and fewer complications. The median postnatal age of patients was eight days (2 days - 92days), and the median weight of patients at the procedure was 2600g (590g - 3900g). The median corrected gestational age of patients at the procedure was 36weeks (23weeks - 46weeks). Summary: This study demonstrated a high success rate and fewer complications of proximal basilic and axillary veins central lines in neonates with difficulties getting intravenous vascular access. This procedure is also safe for Very low birth and extremely low birth Preterm and can be used as central intravenous access for a long time.
... Besides malposition and occlusion, we reported a much lower rate of catheter-related bloodstream infection(0.3 per 1000 catheter days) than those reported in previous studies (from 1.4 to 2.0 per 1000 catheter days) [16,17]. Standard PICC insertion and dressing practice guided by institutional protocols and early removal of unnecessary catheters are essential in preventing PICC-related bloodstream infection. ...
Article
Full-text available
Background: A peripherally inserted central catheter (PICC) with its tip preferably in the vena cava is essential in caring for patients with chronic conditions in general pediatrics. However, PICC-related complications are concerning and warrant further investigations. Objectives: To share the experience of a nurse-inserted peripherally inserted central catheters (PICC) program initiated in a general pediatric department. Methods: A retrospective descriptive cohort study based on a prospectively collected database was conducted. All PICCs inserted in the departments of gastroenterology and pulmonology in a tertiary pediatric center from Dec. 2015 to Dec. 2019 were included in the study. Complications and risk factors were analyzed by comparing cases with and without complications. We also reported arm movements in correcting mal-positioned newly-inserted PICCs. Results: There were 169 cases with a median (IQR) age of 42(6, 108) months who received PICC insertion during a 4-year period. Inflammatory bowel disease was the leading diagnosis accounting for 25.4% (43/169) of all cases. The overall complication rate was 16.4 per 1000 catheter days with malposition and occlusion as the two most common complications. Multivariate models performed by logistic regression demonstrated that young age [p = 0.004, OR (95%CI) = 0.987(0.978, 0.996)] and small PICC diameter (1.9Fr, p = 0.003, OR (95%CI) = 3.936(1.578, 9.818)] were risk factors for PICC complications. Correction of malpositioned catheters was attempted and all succeeded in 9 eligible cases by using arm movements. Conclusion: The nurse-inserted PICC program in general pediatrics is feasible with a low rate of complications. PICC tip malposition and occlusion were two major PICC-related complications when low age and small catheter lumina were major risk factors. Furtherly, arm manipulation potentially is an easy and effective approach for correcting malpositioned newly-inserted PICC catheters.
... In general, neonatal PICC was first described in 1973 by Shaw as a technique for inserting a silicone catheter into the central veins of neonates (4). Since then, there has been significant improvement in the practice of insertion (5). Although PICCs are relatively easy and quick to obtain, they are not risk-free and have been associated with various complications such as occlusion, infection, thrombosis, breakage, and migration. ...
Article
Full-text available
Right-to-left shunt due to abnormal systemic venous drainage to the left heart is among the causes of hypoxemia following Fontan operation. There are conflicting data regarding the closure of the venovenous collaterals (VVCs) post-Fontan, showing decreased survival in older patients. In a child with visceral heterotaxy, we describe a rare fistula draining a right-sided hepatic vein into hepatic venous plexus and a right-sided pulmonary venous atrium. The patient presented with severe hypoxemia post-Fontan and underwent fistula occlusion with AMPLATZER™ Vascular Plug II, successfully improving hemodynamic status with resolution of the hypoxemia. Younger patients with cyanosis due to VVCs may benefit from percutaneous occlusion post-Fontan.
... 3-5 PCVC is a safe and effective technique for prolonged intravenous therapy in NICU. 6,7 Patients in NICU are premature and vulnerable who need considerable efforts for minimal handling and strict limitation of intervention including insertion of PCVC. 8 PCVC insertion should also be done in a short period of time with few to no failed trials. ...
Article
Full-text available
Background: A proper depth of percutaneous central venous catheter (PCVC) is very important to reduce procedural time and prevent various complications in very low birth weight (VLBW) infants who require minimal handling or have a sensitive skin. The objective of this study was to suggest a formula for faster and proper insertion of PCVC in VLBWIs to prevent unintended consequences of patients' conditions. Methods: Prospective data of VLBW infants admitted from June 2015 to January 2018 who had PCVC inserted via the great saphenous vein within seven days after birth were analyzed. Correlations of length of inserted PCVC with body weight, body length, and postmenstrual age at the date of PCVC insertion were determined with a linear regression analysis. Using results of this analysis, a formula to determine the optimal insertion length of PCVC was derived. Coefficient of determination was used to assess how well outcomes were replicated by the formula. Results: The formula to predict the proper insertion length of PCVC via the great saphenous vein at popliteal crease level was obtained as follows: Optimal Length (cm) = 3.8 × Body Weight (kg) + 11.1. With everyday movements such as flexion and extension of the lower extremities, the mean difference in catheter tip position was 7.0 ± 3.9 mm, which was not significant enough to escalate the risk of catheter tip displacement. The rate of catheter-related complications was as low as 4.9% in this study. Conclusions: The formula derived from this study to predict the optimal PCVC insertion length could benefit VLBW infants by reducing procedural time and lowering the risk of complications.
Article
Full-text available
Background: The central line has been frequently used for drug and nutrition supply and regular blood sampling of patients with chronic diseases. However, this procedure is performed in a highly sensitive area and has several potential complications. Therefore, peripherally inserted central catheters (PICC), which have various advantages, are being extensively used. Although the number of PICC procedures is increasing, the anatomy for safe procedures has not yet been properly established. Therefore, we studied basic anatomical information for safe procedures. Methods: We used 20 fixed cadavers (40 arms) donated to the Korea University College of Medicine. The mean age was 76.75 years (range, 48-94 years). After dissection of each arm, the distribution pattern of the basilic vein and close structures was recorded, and some important parameters based on bony landmarks were measured. In addition, the number of vein branches (axillary region) and basilic vein diameter were also checked. Results: The mean length from the insertion site to the right atrium was 38.39 ± 2.63 cm (left) and 34.66 ± 3.60 cm (right), and the basilic vein diameter was 4.93 ± 1.18 mm (left) and 4.08 ± 1.49 mm (right). The data showed significant differences between the left and right arms (P < 0.05). The mean distance from the basilic vein to brachial artery was 8.29 ± 2.78 mm in men and 7.81 ± 2.78 mm in women, while the distance to the ulnar nerve was 5.41 ± 1.67 mm in men and 5.52 ± 2.06 mm in women. Conclusion: According to these results, the right arm has a shorter distance from the insertion site to the right atrium, and the left arm has a wider vein diameter, which is advantageous for the procedure. In addition, the ulnar nerve and brachial artery were located close to or behind the insertion site. Therefore, special attention is required during the procedure to avoid damaging these important structures.
Article
Background: Children with CHD are at risk for neurodevelopmental delays, and length of hospitalisation is a predictor of poorer long-term outcomes. Multiple aspects of hospitalisation impact neurodevelopment, including sleep interruptions, limited holding, and reduced developmental stimulation. We aimed to address modifiable factors by creating and implementing an interdisciplinary inpatient neurodevelopmental care programme in our Heart Institute. Methods: In this quality improvement study, we developed an empirically supported approach to neurodevelopmental care across the continuum of hospitalisation for patients with CHD using three plan-do-study-act cycles. With input from multi-level stakeholders including parents/caregivers, we co-designed interventions that comprised the Cardiac Inpatient Neurodevelopmental Care Optimization (CINCO) programme. These included medical/nursing orders for developmental care practices, developmental kits for patients, bedside developmental plans, caregiver education and support, developmental care rounds, and a specialised volunteer programme. We obtained data from the electronic health record for patients aged 0-2 years admitted for at least 7 days to track implementation. Results: There were 619 admissions in 18 months. Utilisation of CINCO interventions increased over time, particularly for the medical/nursing orders and caregiver handouts. The volunteer programme launch was delayed but grew rapidly and within six months, provided over 500 hours of developmental interaction with patients. Conclusions: We created and implemented a low-cost programme that systematised and expanded upon existing neurodevelopmental care practices in the cardiac inpatient units. Feasibility was demonstrated through increasing implementation rates over time. Key takeaways include the importance of multi-level stakeholder buy-in and embedding processes in existing clinical workflows.
Article
A children's hospital nutritional care team undertook percutaneous insertion of Silastic central venous feeding catheters in patients referred for parenteral nutrition. This represented a shift away from traditional reliance on surgically-inserted catheters. Prospective data relating to the performance of 50 Broviac catheters and 76 Silastic catheters were collected over a period of two years. No differences were seen by comparing catheter life or primary line sepsis. Silastic catheters had a significantly higher rate of occlusion, probably because of their fine bore. The simplicity of percutaneous insertion of the Silastic central venous catheter, together with its comparable performance in relation to surgically-inserted Broviacs make this catheter the first choice in paediatric practice.
Article
In this review the author outlines the case for using parenteral feeding in the case of sick, very low birthweight infants. With modern techniques it is possible to maintain low birthweight infants on total parenteral nutrition for quite long periods and for them to grow and develop during this time. Since however they are born with few body stores to subsidize their extremely rapid rate of growth it would seem reasonable in due course to aim to provide all known nutrients in adequate amounts. Using the results of analyses of fetal bodies, the rates at which elements accumulate in the fetus in utero are calculated. These values provide a useful reference standard for determining nutritional requirements of low birthweight infants and for evaluating the results of parenteral feeding. However, infusing substances at the rate they are accumulated in utero should be done prudently, and with frequent measurements, as such amounts may be harmful if overall growth rate is substantially less than that occurring in utero. The technique of parenteral feeding, though promising, has a definite mortality and morbidity which can only be kept at an acceptable level by obsessional attention to detail. For this reason parenteral feeding is not yet ready for widespread use in the routine care of the low birthweight infant, and should only be used in those units where there are good facilities and abundant well trained staff. This point has recently been emphasized with some force. In time, however, it seems likely that parenteral nutrition will earn itself a place in the routine management of the sick low birthweight infant.
Article
A prospective study of 2,209 intravenous catheters was performed in a multidisciplinary intensive care unit to determine when and why catheters were removed and which sites of insertion were associated with the least morbidity. Techniques of insertion were vigorously supervised. Central and peripheral catheters were cared for by identical protocols. Overt phlebitis or inflammation around the site was 14 times as common with peripheral catheters (353/1,024) than with centrally inserted central catheters (18/713), even though peripheral catheters were removed on the average at 2.9 days and centrally inserted central catheters at 6.2 days. Pneumothorax occurred in seven out of 713 patients with centrally inserted central catheterization, one with hemothorax and two with pneumothoraces requiring thoracostomy tubes. Five were treated successfully with simple catheter aspiration. Three patients out of 1,496 with peripheral or peripherally inserted central catheters required phlebectomy for suppurative thrombophlebitis. We concluded that overall morbidity in critically ill patients is lower from centrally inserted central catheters than peripheral intravenous catheters, with peripherally inserted central catheters in an intermediate position. Supervision of techniques of insertion has to be kept at a high level to keep complications of central catheterization at an acceptable level. Peripheral catheter sites would be better maintained with more frequent replacement of the catheter.
Article
To date, no research articles have been published that explore the practice of using guidewires for placement of peripherally inserted central catheters. The literature contains speculations regarding the pros and cons of guidewire use. However, no studies to date have compared patient outcomes when peripherally inserted central catheter lines are inserted with and without guidewires. To examine the use of guidewires for peripherally inserted central lines, a comparative study was conducted at two acute care facilities, one using guidewires for insertion and one inserting peripherally inserted central catheter lines without guidewires. 109 catheters were studied between January 1, 1990 and January 1, 1991. The primary focus of this study was to examine whether guidewire use places patients at higher risk for catheter-related complications, particularly phlebitis. No significant differences in phlebitis rates between the two study sites were found. Other catheter-related and noncatheter-related complications were similar between the two facilities. The results of this study do not support the belief that guidewire use increases complication rates.
Article
Management of parenteral therapies in the home or nonacute setting is essential. Peripherally inserted long-line catheters establish venous access in patients in a safe, cost-effective, and improved manner. Data were collected on 130 cases from 24 offices in 16 states. The most frequently occurring types of therapies used were antibiotic, pain control, and parenteral nutrition. Average length of therapy was 20.4 days. The major reasons for catheter removal other than completion of therapy (58%) were occlusion (14%), breakage (5%), and phlebitis (4%).
Article
Peripherally inserted central catheter lines (PICCs) are the "new kids on the block" for intravenous therapy. This paper reports on the development of a protocol and training program for nurses at a 350-bed community hospital. The paper describes the development and implementation of this pilot program in 25 patients over a 1-year period.
Article
Reliable vascular access is essential for any type of intravenous therapy. The movement of many intravenous therapies to the home setting has placed a greater burden on home care nurses to maintain reliable vascular access. In the past, when peripheral venous access became unmanageable, a central venous device such as a tunneled silastic catheter or a polyurethane subclavian line was placed. Peripherally inserted central venous catheters now offer an alternative to this type of device. These devices, nicknamed long-arm or long-line catheters, are providing reliable vascular access for many therapies. They are inserted by specially trained nurses in the home. They offer fewer complications, decreased cost and improved patient comfort. The phlebitis rate and other catheter-related complications are examined. Nurse training and insertion procedures are explored in this small pilot study.
Article
Use of a single percutaneous silastic IV catheter for cystic fibrosis hospitalizations was evaluated among 23 patients during 45 hospitalizations. Patients ages ranged from 4 to 20 years and weights from 18 to 60 kg. Percutaneous silastic catheters were used for infusion of all IV antibiotics and IV fluids. Catheters remained in place for a total of 549 patient days (mean 12.2, range 2-34). No patient demonstrated clinical signs of local infection or sepsis. Thirty six catheters served as the single IV access for a patient's entire hospitalization. Nine catheters were removed because of discomfort, obstruction, or mechanical dysfunction before the conclusion of the hospitalization. A single, percutaneously placed silastic catheter appears to be a safe and effective way of maintaining IV access throughout the duration of hospitalization for cystic fibrosis exacerbations.